未登录

H

Hong Chang

teva pharmaceutical industries

H指数:26

被引数:2,633

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer

ONCOLOGY REPORTS

IF3.9

2024-11-291

PRE

Sodium arsenite and dimethylarsenic acid induces apoptosis in OC3 oral cavity cancer cells

MOLECULAR MEDICINE REPORTS

IF3.5

2022-12-131

OAAI

ROS-responsive polypeptides for intracellular protein delivery and CRISPR/Cas9 gene editing

用于细胞内蛋白质递送和CRISPR/Cas9基因编辑的ROS响应多肽

IF10.9

2022-10-0121

PRE

MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2020-11-2816

OAAI

Off-on switching of enzyme activity by near-infrared light-induced photothermal phase transition of nanohybrids

SCIENCE ADVANCES

IF12.5

2019-08-0267

OAAI

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model

SCIENTIFIC REPORTS

IF3.9

2019-07-1741

OAAI

Natural Polyphenols Augment Cytosolic Protein Delivery by a Functional Polymer

天然多酚通过功能聚合物增强胞质蛋白的递送

CHEMISTRY OF MATERIALS

IF7

2019-03-1498

PREAI

Liver regeneration accelerates hepatitis B virus-related tumorigenesis of hepatocellular carcinoma

MOLECULAR ONCOLOGY

IF4.5

2018-05-2910

OAAI

The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2017-08-2620

OAAI

A Combination of Guanidyl and Phenyl Groups on a Dendrimer Enables Efficient siRNA and DNA Delivery

BIOMACROMOLECULES

IF5.4

2017-07-1759

PREAI

Rational Design of a Polymer with Robust Efficacy for Intracellular Protein and Peptide Delivery

IF9.1

2017-02-20163

PREAI

Inhibition of breast cancer cell metastasis with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFbeta/miR-21 signaling

MOLECULAR CANCER RESEARCH

IF4.7

2016-11-100

PRE

MiR-200 is involved in anti-invasive activity of sulindac in colon cancer

MOLECULAR CANCER RESEARCH

IF4.7

2016-11-100

PRE

Sulindac inhibition of tumor cell transformation

MOLECULAR CANCER RESEARCH

IF4.7

2016-11-100

PRE

CRISPR/cas9, an innovative genomic tool to knock down microRNA

CANCER RESEARCH

IF16.6

2016-07-150

PRE

CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo

SCIENTIFIC REPORTS

IF3.9

2016-02-29207

OAAI

RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer Drugs

MOLECULAR CANCER THERAPEUTICS

IF5.5

2016-02-0716

OA

Screening of efficient polymers for siRNA delivery in a library of hydrophobically modified polyethyleneimines

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2016-01-0149

PREAI

Stimuli-responsive dendrimers in drug delivery

BIOMATERIALS SCIENCE

IF5.7

2016-01-01192

PREAI

SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor

CLINICAL CANCER RESEARCH

IF10.2

2015-12-1436

OAAI